Literature DB >> 19873836

An approach to evaluating the therapeutic misconception.

Scott Y H Kim1, Lauren Schrock, Renee M Wilson, Samuel A Frank, Robert G Holloway, Karl Kieburtz, Raymond G de Vries.   

Abstract

Entities:  

Mesh：

Year:  2009        PMID： 19873836      PMCID： PMC3360887     

Source DB:  PubMed          Journal:  IRB        ISSN： 0193-7758


× No keyword cloud information.
  24 in total

1.  Ethical significance of ethics-related empirical research.

Authors:  Franklin G Miller
Journal:  J Natl Cancer Inst       Date:  2002-12-18       Impact factor: 13.506

2.  Does informed consent to research require comprehension?

Authors:  Gopal Sreenivasan
Journal:  Lancet       Date:  2003-12-13       Impact factor: 79.321

3.  Misunderstanding in clinical research: distinguishing therapeutic misconception, therapeutic misestimation, and therapeutic optimism.

Authors:  Sam Horng; Christine Grady
Journal:  IRB       Date:  2003 Jan-Feb

4.  Therapeutic misconception in clinical research: frequency and risk factors.

Authors:  Paul S Appelbaum; Charles W Lidz; Thomas Grisso
Journal:  IRB       Date:  2004 Mar-Apr

5.  Therapeutic misconception and the appreciation of risks in clinical trials.

Authors:  Charles W Lidz; Paul S Appelbaum; Thomas Grisso; Michelle Renaud
Journal:  Soc Sci Med       Date:  2004-05       Impact factor: 4.634

6.  The therapeutic misconception at 25: treatment, research, and confusion.

Authors:  Jonathan Kimmelman
Journal:  Hastings Cent Rep       Date:  2007 Nov-Dec       Impact factor: 2.683

7.  Transplantation of embryonic dopamine neurons for severe Parkinson's disease.

Authors:  C R Freed; P E Greene; R E Breeze; W Y Tsai; W DuMouchel; R Kao; S Dillon; H Winfield; S Culver; J Q Trojanowski; D Eidelberg; S Fahn
Journal:  N Engl J Med       Date:  2001-03-08       Impact factor: 91.245

8.  The therapeutic misconception: informed consent in psychiatric research.

Authors:  P S Appelbaum; L H Roth; C Lidz
Journal:  Int J Law Psychiatry       Date:  1982

Review 9.  Deep brain stimulation for Parkinson's disease: disrupting the disruption.

Authors:  Andres M Lozano; Jonathan Dostrovsky; Robert Chen; Peter Ashby
Journal:  Lancet Neurol       Date:  2002-08       Impact factor: 44.182

10.  Ethics of phase 1 oncology studies: reexamining the arguments and data.

Authors:  Manish Agrawal; Ezekiel J Emanuel
Journal:  JAMA       Date:  2003-08-27       Impact factor: 56.272
View more
  23 in total

1.  Comparison of enrollees and decliners of Parkinson disease sham surgery trials.

Authors:  Scott Y H Kim; Renee M Wilson; H Myra Kim; Robert G Holloway; Raymond G De Vries; Samuel A Frank; Karl Kieburtz
Journal:  Mov Disord       Date:  2012-02-07       Impact factor: 10.338

2.  Novel therapies, high-risk pediatric research, and the prospect of benefit: learning from the ethical disagreements.

Authors:  Inmaculada de Melo-Martín; Dolan Sondhi; Ronald G Crystal
Journal:  Mol Ther       Date:  2012-06       Impact factor: 11.454

3.  Are therapeutic motivation and having one's own doctor as researcher sources of therapeutic misconception?

Authors:  Scott Y H Kim; Raymond De Vries; Sonali Parnami; Renee Wilson; H Myra Kim; Samuel Frank; Robert G Holloway; Karl Kieburtz
Journal:  J Med Ethics       Date:  2014-05-22       Impact factor: 2.903

4.  Motivations and Decision Making Processes of Men With X-linked Retinoschisis Considering Participation in an Ocular Gene Therapy Trial.

Authors:  Amy Turriff; Delphine Blain; Morgan Similuk; Barbara Biesecker; Henry Wiley; Catherine Cukras; Paul A Sieving
Journal:  Am J Ophthalmol       Date:  2019-03-16       Impact factor: 5.258

5.  Randomized evaluation of trial acceptability by INcentive (RETAIN): Study protocol for two embedded randomized controlled trials.

Authors:  Dustin C Krutsinger; Jacqueline McMahon; Alisa J Stephens-Shields; Brian Bayes; Steven Brooks; Brian L Hitsman; Su Fen Lubitz; Celine Reyes; Robert A Schnoll; S Ryan Greysen; Ashley Mercede; Mitesh S Patel; Catherine Reale; Fran Barg; Jason Karlawish; Daniel Polsky; Kevin G Volpp; Scott D Halpern
Journal:  Contemp Clin Trials       Date:  2018-11-08       Impact factor: 2.226

6.  A Qualitative Analysis of Ethical Perspectives on Recruitment and Consent for Human Intracranial Electrophysiology Studies.

Authors:  Joncarmen V Mergenthaler; Winston Chiong; Daniel Dohan; Josh Feler; Cailin R Lechner; Philip A Starr; Jalayne J Arias
Journal:  AJOB Neurosci       Date:  2021-01

7.  You never call, you never write: why return of 'omic' results to research participants is both a good idea and a moral imperative.

Authors:  Misha Angrist
Journal:  Per Med       Date:  2011-11       Impact factor: 2.512

8.  The culture of faith and hope: patients' justifications for their high estimations of expected therapeutic benefit when enrolling in early phase oncology trials.

Authors:  Daniel P Sulmasy; Alan B Astrow; M Kai He; Damon M Seils; Neal J Meropol; Ellyn Micco; Kevin P Weinfurt
Journal:  Cancer       Date:  2010-08-01       Impact factor: 6.860

9.  Conflicts among multinational ethical and scientific standards for clinical trials of therapeutic interventions.

Authors:  Jacob M Kolman; Nelda P Wray; Carol M Ashton; Danielle M Wenner; Anna F Jarman; Baruch A Brody
Journal:  J Law Med Ethics       Date:  2012       Impact factor: 1.718

10.  Research participants' high expectations of benefit in early-phase oncology trials: are we asking the right question?

Authors:  Kevin P Weinfurt; Damon M Seils; Li Lin; Daniel P Sulmasy; Alan B Astrow; Herbert I Hurwitz; Roger B Cohen; Neal J Meropol
Journal:  J Clin Oncol       Date:  2012-10-22       Impact factor: 44.544
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.